Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xian Yimucao Capsule (also known as Fresh Leonurus japonicus Capsule or Fresh Motherwort Capsule) is a traditional Chinese patent medicine developed by the Zhejiang Institute of Traditional Chinese Medicine and manufactured by Zhejiang Dade Pharmaceutical. Formulated from fresh Leonurus japonicus (motherwort) harvested during its pre-flowering stage, the capsule is designed to promote blood circulation, regulate menstruation, and stimulate uterine contraction. It is approved in China for the treatment of irregular menstruation, postpartum lochia, postpartum hemorrhage, and uterine subinvolution following childbirth or medical abortion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xian Yimucao Capsule.